Impact of hyperhydration on fluid overload and hematopoietic cell transplant after post-transplant cyclophosphamide-based graft-versus-host-disease prophylaxis

被引：0

作者：

Samuels, Diana T. ^{[1
]}

Yao, Janny M. ^{[1
]}

Samara, Yazeed ^{[2
]}

Yang, Dongyun ^{[3
]}

Mokhtari, Sally ^{[4
]}

Tiemann, Katrin ^{[4
]}

Otoukesh, Salman ^{[2
]}

Arslan, Shukaib ^{[2
]}

Pourhassan, Hoda ^{[2
]}

Wu, Stephanie ^{[5
]}

Blackmon, Amanda ^{[2
]}

Agrawal, Vaibhav ^{[2
]}

Amanam, Idoroenyi ^{[2
]}

Ali, Haris ^{[2
]}

Salhotra, Amandeep ^{[2
]}

Aldoss, Ibrahim ^{[2
]}

Ball, Brian ^{[2
]}

Koller, Paul ^{[2
]}

Aribi, Ahmed ^{[2
]}

Sandhu, Karamjeet ^{[2
]}

Pullarkat, Vinod ^{[2
]}

Artz, Andrew ^{[2
]}

Smith, Eileen ^{[2
]}

Stewart, Forrest ^{[2
]}

Becker, Pamela ^{[2
]}

Stein, Anthony ^{[2
]}

Marcucci, Guido ^{[2
]}

Forman, Stephen J. ^{[2
]}

Nakamura, Ryotaro ^{[2
]}

Al Malki, Monzr M. ^{[2
]}

机构：

[1] City Hope Natl Med Ctr, Dept Pharm, Duarte, CA USA

[2] City Hope Natl Med Ctr, Dept Hematol & Hematopoiet Cell Transplantat, Duarte, CA 91010 USA

[3] City Hope Natl Med Ctr, Dept Computat & Quantitat Med, Div Biostat, Duarte, CA USA

[4] City Hope Natl Med Ctr, Dept Clin & Translat Project Dev, Duarte, CA USA

[5] City Hope Natl Med Ctr, Div Cardiol, Dept Internal Med, Duarte, CA USA

来源：

FRONTIERS IN IMMUNOLOGY | 2025年 / 16卷

关键词：

allogeneic hematopoietic cell transplantation; post-transplant cyclophosphamide; hyperhydration; hemorrhagic cystitis; fluid overload; fluid retention; fluid toxicity; weight gain; BONE-MARROW-TRANSPLANTATION; HIGH-DOSE CHEMOTHERAPY; HEMORRHAGIC CYSTITIS; SINGLE-AGENT; PREVENTION; BUSULFAN; MESNA;

D O I：

10.3389/fimmu.2025.1543099

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Introduction Hemorrhagic cystitis (HC) is an early complication after hematopoietic cell transplant (HCT) with post-transplant cyclophosphamide (PTCy). Hyperhydration can reduce HC, but may lead to fluid overload (FO), which has been associated with higher non-relapse mortality (NRM) after HCT. Methods The objectives of this study were to grade FO between days 3 and 8 based on weight gain, diuretic therapy, and FO-related organ dysfunction and analyze the impact of FO on non-relapse mortality (NRM) and subsequently on overall survival (OS) of patients undergoing HCT with PTCy-based GvHD prophylaxis. Results Two hundred seventy-five patients who received PTCy at City of Hope from 2009 to 2018 were included. A majority, 270 (98%) patients were diagnosed with early FO from day 3-8 post HCT, of whom 248 (92%) experienced mild to moderate (grade 1-2) FO, and 22 (8%) experienced severe (grade 3-4) FO. Day 100 NRM was significantly higher in patients with grade 3-4 FO compared to patients with grade 0-1 (59.1 vs 1.7%, CI: 0.006-0.053p<0.001) and grade 2 (59.1 vs 8.8%, CI: 0.043-0.178, p<0.001) FO. At 2 years, OS and DFS were significantly lower in patients who experienced grade 3-4 FO compared to patients who had grade 0-1 FO (31.8% vs 68.2%, CI: 0.616-0.755, p<0.001) and grade 2 FO (31.8% vs 62.5%; CI: 0.527-0.741, p<0.001). Additionally, each 5% weight gain from baseline was associated with higher NRM (HR=1.91, 95%CI: 1.64-2.23, p<0.001). Conclusion Almost all patients undergoing hyperhydration for PTCy-induced HC will present with FO. Grade 3-4 FO is uncommon and associated with poor clinical outcomes. Weight gain could be used as an early and possibly modifiable indicator of FO.

引用

页数：11

共 26 条

[11] Matz E.L., Hsieh M.H., Review of advances in uroprotective agents for cyclophosphamide- and ifosfamide-induced hemorrhagic cystitis, Urology, 100, (2017)
[12] Ruggeri A., Roth-Guepin G., Battipaglia G., Mamez A.C., Malard F., Gomez A., Et al., Incidence and risk factors for hemorrhagic cystitis in unmanipulated haploidentical transplant recipients, Transplant Infect disease: an Off J Transplant Society, 17, (2015)
[13] Robinson D., Schulz G., Langley R., Donze K., Winchester K., Rodgers C., Evidence-based practice recommendations for hydration in children and adolescents with cancer receiving intravenous cyclophosphamide, J Pediatr Oncol nursing: Off J Assoc Pediatr Oncol Nurses, 31, (2014)
[14] Droller M.J., Saral R., Santos G., Prevention of cyclophosphamide-induced hemorrhagic cystitis, Urology, 20, (1982)
[15] Shepherd J.D., Pringle L.E., Barnett M.J., Klingemann H.G., Reece D.E., Phillips G.L., Mesna versus hyperhydration for the prevention of cyclophosphamide-induced hemorrhagic cystitis in bone marrow transplantation, J Clin oncology: Off J Am Soc Clin Oncol, 9, (1991)
[16] Damron B.H., Brant J.M., Belansky H.B., Friend P.J., Samsonow S., Schaal A., Putting evidence into practice: prevention and management of bleeding in patients with cancer, Clin J Oncol nursing, 13, (2009)
[17] Vose J.M., Reed E.C., Pippert G.C., Anderson J.R., Bierman P.J., Kessinger A., Et al., Mesna compared with continuous bladder irrigation as uroprotection during high-dose chemotherapy and transplantation: a randomized trial, J Clin oncology: Off J Am Soc Clin Oncol, 11, (1993)
[18] Rondon G., Saliba R.M., Chen J., Ledesma C., Alousi A.M., Oran B., Et al., Impact of fluid overload as new toxicity category on hematopoietic stem cell transplantation outcomes, Biol Blood marrow transplantation: J Am Soc Blood Marrow Transplantation, 23, (2017)
[19] Ngo D., Mac S., Yang D., Mokhtari S., Chen J., Ali H., Et al., Hemorrhagic cystitis in patients undergoing allogeneic hematopoietic cell transplant with post transplant cyclophosphamide as gvHD prophylaxis, Blood, 136, (2020)
[20] Rondon-Clavo C., Scordo M., Hilden P., Shah G.L., Cho C., Maloy M.A., Et al., Early fluid overload is associated with an increased risk of nonrelapse mortality after ex vivo CD34-selected allogeneic hematopoietic cell transplantation, Biol Blood marrow transplantation: J Am Soc Blood Marrow Transplantation, 24, (2018)

← 1 2 3 →